SOPHiA GENETICS S.A. (SOPH) Stock Analysis

What SOPHiA GENETICS S.A. does

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Key metrics

ETFs linked to SOPH

Broad-market and Healthcare sector ETFs an investor holding SOPHiA GENETICS S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SOPH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SOPHiA GENETICS S.A.?

SOPHiA GENETICS S.A. trades under the ticker SOPH on NASDAQ.

Which exchange is SOPH listed on?

SOPH is listed on NASDAQ.

What sector does SOPHiA GENETICS S.A. operate in?

SOPHiA GENETICS S.A. is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze SOPH in a portfolio?

PortView shows SOPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.